Evidence map›Paper›PMID 41411372›Full record

ArticlePLoS neglected tropical diseases2025

A colorimetric method for detecting virulent bacteriophage to Vibrio cholerae in fecal and environmental samples.

Wensheng Luo, Diana Dinowitz, Andrew Camilli, Jason R Andrews, Kesia Esther da Silva, Amanda K Debes, Md A Sayeed, Eric J Nelson, David A Sack

Abstract readEvaluation Study
In one paragraph

Article in PLoS neglected tropical diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Wensheng LuoDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Diana DinowitzDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Andrew CamilliDepartment of Molecular Biology & Microbiology, Tufts University School of Medicine, Boston, Massachusetts United States of America.
Jason R AndrewsDivision of Infectious Diseases and Geographic Medicine, School of Medicine, Stanford University, Stanford, California, United States of America.
Kesia Esther da SilvaDivision of Infectious Diseases and Geographic Medicine, School of Medicine, Stanford University, Stanford, California, United States of America.
Amanda K DebesDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Md A SayeedDepartments of Environmental and Global Health and Pediatrics, Emerging Pathogens Institute, University of Florida, Gainesville, Florida, United States of America.
Eric J NelsonDepartments of Environmental and Global Health and Pediatrics, Emerging Pathogens Institute, University of Florida, Gainesville, Florida, United States of America.
David A SackDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.ORCID 0000-0002-9338-5119

Funding

Epidemiology and Ecology of Cholera in AfricaR01AI123422 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Amanda Kay Debes, DAVID A SACK · 2017 to 2026
$6.6M
Phage Resistance in Emergent Vibrio cholerae and Phage Prophylaxis of CholeraR37AI055058 · NIAID · TUFTS UNIVERSITY BOSTON · PI Andrew Camilli · 2020 to 2026
$3.4M
Novel tools for measuring typhoid vaccine impactR01AI181283 · NIAID · STANFORD UNIVERSITY · PI Jason Randolph Andrews, Richelle C Charles · 2024 to 2026
$2.2M
NIAID NIH HHS R01 AI123422NIAID NIH HHS R01 AI181283NIAID NIH HHS R37 AI055058
6 · The paper itself

Abstract

backgroundVibrio cholerae are often infected with pathogen-specific virulent bacteriophages (phages) that may be found associated with V. cholerae or independently from the bacteria, especially in environmental water samples. When detected, these phages can serve as a surrogate for detection of V. cholerae and they also have an important role in the ecology of V. cholerae. Vibriophages can be detected using plaque or molecular (PCR) assays, but these methods are time-consuming and require specialized laboratory resources. METHODOLOGY: To increase the accessibility of phage detection for epidemiologic applications, we developed a simple, rapid, and inexpensive colorimetric assay to detect vibriophage that can be scaled quickly to screen large numbers of samples. The assay uses resazurin and V. cholerae AC6169 that is susceptible to vibriophages ICP1, 2, and 3. Resazurin is a dye that turns from blue to pink when added to a culture broth with growing bacteria. We hypothesized that when a bacteria-free test sample, such as filtered wastewater containing vibriophage is added to culture broth with AC6169 and resazurin, the phages will lyse the bacteria preventing their growth, and the color of the broth will remain blue. However, if there are no vibriophages in the sample, the bacteria will grow rapidly, and the culture broth will turn pink.

resultsWe developed the assay using ICP1 spiked samples of environmental water, stool and frozen bile peptone and found it to be sensitive with a limit of detection of 4-40 plaque forming units/ml.

conclusionThis colorimetric assay provides a convenient method to detect vibriophages on a larger scale than was possible earlier. Its use should help to better understand the role of vibriophage as a surrogate for detecting V. cholerae and better understand their role in the pathogenesis, ecology, and epidemiology of cholera.

Indexed as

BacteriophagesColorimetryFecesVibrio choleraeHumansOxazinesXanthenesOxazinesresazurinXanthenes

Identifiers

PMID41411372
PMCPMC12725621

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.